Skip to main content
Top

Tip

Swipe om te navigeren naar een ander artikel

01-10-2022 | Original Article

Effectiveness of Psychotropic Medications in Children with Prenatal Alcohol and Drug Exposures: A Case Series and Model of Care

Auteurs: Gaby J. Ritfeld, Julie A. Kable, Jennifer E. Holton, Claire D. Coles

Gepubliceerd in: Child Psychiatry & Human Development

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Fetal Alcohol Spectrum Disorders affect up to 5% of the population, with additional children affected by prenatal drug exposures. The majority of these children display symptoms of ADHD and poor emotional dysregulation, a common reason for seeking psychiatric care. However, high prevalence of comorbid look-alike symptoms and limited availability of evidence-based treatments complicates psychiatric decision making in this population. The goal of the current study is to report on the effectiveness of psychotropic medications in a case series of 16 individuals with prenatal alcohol/drug exposure and propose a model for psychiatric care for this population. In addition to traditional subjective reports, an objective continuous performance test (T.O.V.A.®) was used to aid with guiding treatment. We found that T.O.V.A.®-scores improved on average from − 6.5 to − 2.9 with our psychiatric approach (p = 0.03). T.O.V.A.®-measurements were helpful in differentiating ADHD symptoms from comorbid symptoms and to guide decision-making on starting and changing medications.
Literatuur
1.
go back to reference May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D et al (2018) Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities. JAMA 319:474–482 CrossRef May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D et al (2018) Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities. JAMA 319:474–482 CrossRef
2.
go back to reference Makadia LD, Roper PJ, Andrews JO, Tingen MS (2017) Tobacco use and smoke exposure in children: new trends, harm, and strategies to improve health outcomes. Curr Allergy Asthma Rep 17:55 CrossRef Makadia LD, Roper PJ, Andrews JO, Tingen MS (2017) Tobacco use and smoke exposure in children: new trends, harm, and strategies to improve health outcomes. Curr Allergy Asthma Rep 17:55 CrossRef
3.
go back to reference Buckingham-Howes S, Berger SS, Scaletti LA, Black MM (2013) Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics 131:e1917-1936 CrossRef Buckingham-Howes S, Berger SS, Scaletti LA, Black MM (2013) Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics 131:e1917-1936 CrossRef
4.
go back to reference O’Connor MJ, Paley B (2009) Psychiatric conditions associated with prenatal alcohol exposure. Dev Disabil Res Rev 15:225–234 CrossRef O’Connor MJ, Paley B (2009) Psychiatric conditions associated with prenatal alcohol exposure. Dev Disabil Res Rev 15:225–234 CrossRef
5.
go back to reference Mattson SN, Bernes GA, Doyle LR (2019) Fetal Alcohol Spectrum Disorders: a review of the neurobehavioral deficits associated with prenatal alcohol exposure. Alcohol Clin Exp Res 43:1046–1062 PubMedPubMedCentral Mattson SN, Bernes GA, Doyle LR (2019) Fetal Alcohol Spectrum Disorders: a review of the neurobehavioral deficits associated with prenatal alcohol exposure. Alcohol Clin Exp Res 43:1046–1062 PubMedPubMedCentral
6.
go back to reference Jones KL (2011) The effects of alcohol on fetal development. Birth Defects Res C Embryo Today 93:3–11 CrossRef Jones KL (2011) The effects of alcohol on fetal development. Birth Defects Res C Embryo Today 93:3–11 CrossRef
7.
go back to reference Mukherjee RAS, Cook PA, Norgate SH, Price AD (2019) Neurodevelopmental outcomes in individuals with Fetal Alcohol Spectrum Disorder (FASD) with and without exposure to neglect: clinical cohort data from a national FASD diagnostic clinic. Alcohol 76:23–28 CrossRef Mukherjee RAS, Cook PA, Norgate SH, Price AD (2019) Neurodevelopmental outcomes in individuals with Fetal Alcohol Spectrum Disorder (FASD) with and without exposure to neglect: clinical cohort data from a national FASD diagnostic clinic. Alcohol 76:23–28 CrossRef
8.
go back to reference Chambers CD, Coles C, Kable J, Akshoomoff N, Xu R, Zellner JA et al (2019) Fetal Alcohol Spectrum Disorders in a Pacific Southwest City: maternal and child characteristics. Alcohol Clin Exp Res 43:2578–2590 CrossRef Chambers CD, Coles C, Kable J, Akshoomoff N, Xu R, Zellner JA et al (2019) Fetal Alcohol Spectrum Disorders in a Pacific Southwest City: maternal and child characteristics. Alcohol Clin Exp Res 43:2578–2590 CrossRef
9.
go back to reference Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN (2007) Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics 119:e733-741 CrossRef Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN (2007) Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics 119:e733-741 CrossRef
10.
go back to reference Frankel F, Paley B, Marquardt R, O’Connor M (2006) Stimulants, neuroleptics, and children’s friendship training for children with Fetal Alcohol Spectrum Disorders. J Child Adolesc Psychopharmacol 16:777–789 CrossRef Frankel F, Paley B, Marquardt R, O’Connor M (2006) Stimulants, neuroleptics, and children’s friendship training for children with Fetal Alcohol Spectrum Disorders. J Child Adolesc Psychopharmacol 16:777–789 CrossRef
11.
go back to reference Ritfeld GJ, Kable JA, Holton JE, Coles CD (2022) Psychopharmacological treatments in children with Fetal Alcohol Spectrum Disorders: a review. Child Psychiatry Hum Dev 53:268–277 CrossRef Ritfeld GJ, Kable JA, Holton JE, Coles CD (2022) Psychopharmacological treatments in children with Fetal Alcohol Spectrum Disorders: a review. Child Psychiatry Hum Dev 53:268–277 CrossRef
12.
go back to reference Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H (1998) Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study. J Child Adolesc Psychopharmacol 8:39–48 CrossRef Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H (1998) Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study. J Child Adolesc Psychopharmacol 8:39–48 CrossRef
13.
go back to reference O’Malley KD, Koplin B, Dohner VA (2000) Psychostimulant clinical response in fetal alcohol syndrome. Can J Psychiatry 45:90–91 PubMed O’Malley KD, Koplin B, Dohner VA (2000) Psychostimulant clinical response in fetal alcohol syndrome. Can J Psychiatry 45:90–91 PubMed
14.
go back to reference Doig J, McLennan JD, Gibbard WB (2008) Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with Fetal Alcohol Spectrum Disorder. J Child Adolesc Psychopharmacol 18:365–371 CrossRef Doig J, McLennan JD, Gibbard WB (2008) Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with Fetal Alcohol Spectrum Disorder. J Child Adolesc Psychopharmacol 18:365–371 CrossRef
15.
go back to reference Snyder JNJ, Snyder R, Block G (1997) A study of stimulant medication in children with FAS. In: Streissguth AKJ (ed) Overcoming and preventing secondary disabilities in fetal alcohol syndrome and fetal alcohol effects. University of Washington Press, Seattle, pp 64–77 Snyder JNJ, Snyder R, Block G (1997) A study of stimulant medication in children with FAS. In: Streissguth AKJ (ed) Overcoming and preventing secondary disabilities in fetal alcohol syndrome and fetal alcohol effects. University of Washington Press, Seattle, pp 64–77
16.
go back to reference Coe JSJ, Riley K, Waltermire J, Hagerman R (2001) A survey of medication responses in children and adolescents with fetal alcohol syndrome. Mental Health Aspects Dev Disabil 4:148–155 Coe JSJ, Riley K, Waltermire J, Hagerman R (2001) A survey of medication responses in children and adolescents with fetal alcohol syndrome. Mental Health Aspects Dev Disabil 4:148–155
17.
go back to reference Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894–921 CrossRef Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894–921 CrossRef
18.
go back to reference Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE (1997) A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res 21:150–161 CrossRef Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE (1997) A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res 21:150–161 CrossRef
19.
go back to reference Wozniak JR, Fuglestad AJ, Eckerle JK, Fink BA, Hoecker HL, Boys CJ et al (2015) Choline supplementation in children with Fetal Alcohol Spectrum Disorders: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 102:1113–1125 CrossRef Wozniak JR, Fuglestad AJ, Eckerle JK, Fink BA, Hoecker HL, Boys CJ et al (2015) Choline supplementation in children with Fetal Alcohol Spectrum Disorders: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 102:1113–1125 CrossRef
20.
go back to reference Nguyen TT, Risbud RD, Mattson SN, Chambers CD, Thomas JD (2016) Randomized, double-blind, placebo-controlled clinical trial of choline supplementation in school-aged children with Fetal Alcohol Spectrum Disorders. Am J Clin Nutr 104:1683–1692 CrossRef Nguyen TT, Risbud RD, Mattson SN, Chambers CD, Thomas JD (2016) Randomized, double-blind, placebo-controlled clinical trial of choline supplementation in school-aged children with Fetal Alcohol Spectrum Disorders. Am J Clin Nutr 104:1683–1692 CrossRef
21.
go back to reference Wozniak JR, Fink BA, Fuglestad AJ, Eckerle JK, Boys CJ, Sandness KE et al (2020) Four-year follow-up of a randomized controlled trial of choline for neurodevelopment in Fetal Alcohol Spectrum Disorder. J Neurodev Disord 12:9 CrossRef Wozniak JR, Fink BA, Fuglestad AJ, Eckerle JK, Boys CJ, Sandness KE et al (2020) Four-year follow-up of a randomized controlled trial of choline for neurodevelopment in Fetal Alcohol Spectrum Disorder. J Neurodev Disord 12:9 CrossRef
22.
go back to reference Mela M, Okpalauwaekwe U, Anderson T, Eng J, Nomani S, Ahmed A et al (2018) The utility of psychotropic drugs on patients with Fetal Alcohol Spectrum Disorder (FASD): a systematic review. Psychiatry Clin Psychopharmacol 28:436–445 CrossRef Mela M, Okpalauwaekwe U, Anderson T, Eng J, Nomani S, Ahmed A et al (2018) The utility of psychotropic drugs on patients with Fetal Alcohol Spectrum Disorder (FASD): a systematic review. Psychiatry Clin Psychopharmacol 28:436–445 CrossRef
23.
go back to reference Elliott CD (2007) Differential ability scales (2nd ed). Can J School Psychol 22:128–132. Elliott CD (2007) Differential ability scales (2nd ed). Can J School Psychol 22:128–132.
24.
go back to reference Sparrow S, Balla D, Cichetti, D (1984) The vineland adaptive behavior scales: american guidance service. Circle Pines Sparrow S, Balla D, Cichetti, D (1984) The vineland adaptive behavior scales: american guidance service. Circle Pines
25.
go back to reference Fernhoff PM, Smith IE, Falek A (1980) Dysmorphia checklist. Document available through the maternal substance abuse and child development project. Division of Psychiatry, Emory University, Atlanta Fernhoff PM, Smith IE, Falek A (1980) Dysmorphia checklist. Document available through the maternal substance abuse and child development project. Division of Psychiatry, Emory University, Atlanta
26.
go back to reference Coles CD, Gailey AR, Mulle JG, Kable JA, Lynch ME, Jones KL (2016) A comparison among 5 methods for the clinical diagnosis of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res 40:1000–1009 CrossRef Coles CD, Gailey AR, Mulle JG, Kable JA, Lynch ME, Jones KL (2016) A comparison among 5 methods for the clinical diagnosis of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res 40:1000–1009 CrossRef
27.
go back to reference Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB et al (2001) Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168–179 CrossRef Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB et al (2001) Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168–179 CrossRef
28.
go back to reference Coles CD, Kable JA, Taddeo E, Strickland DC (2015) A metacognitive strategy for reducing disruptive behavior in children with Fetal Alcohol Spectrum Disorders: GoFAR pilot. Alcohol Clin Exp Res 39:2224–2233 CrossRef Coles CD, Kable JA, Taddeo E, Strickland DC (2015) A metacognitive strategy for reducing disruptive behavior in children with Fetal Alcohol Spectrum Disorders: GoFAR pilot. Alcohol Clin Exp Res 39:2224–2233 CrossRef
29.
go back to reference Achenbach TM (2017) Achenbach system of empirically based assessment (ASEBA). In: Kreutzer J, DeLuca J, Caplan B (eds) Encyclopedia of clinical neuropsychology. Springer, Cham, pp 1–7 Achenbach TM (2017) Achenbach system of empirically based assessment (ASEBA). In: Kreutzer J, DeLuca J, Caplan B (eds) Encyclopedia of clinical neuropsychology. Springer, Cham, pp 1–7
30.
go back to reference Greenberg LM (2011) The test of variables of attention (version 8.0) [computer software]. The TOVA Company, Los Alamitos Greenberg LM (2011) The test of variables of attention (version 8.0) [computer software]. The TOVA Company, Los Alamitos
31.
go back to reference Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57:289–300
32.
go back to reference Randall S, Hannigan JH (1999) In utero alcohol and postnatal methylphenidate: locomotion and dopamine receptors. Neurotoxicol Teratol 21:587–593 CrossRef Randall S, Hannigan JH (1999) In utero alcohol and postnatal methylphenidate: locomotion and dopamine receptors. Neurotoxicol Teratol 21:587–593 CrossRef
33.
go back to reference Hannigan JH, Pilati ML (1991) The effects of chronic postweaning amphetamine on rats exposed to alcohol in utero: weight gain and behavior. Neurotoxicol Teratol 13:649–656 CrossRef Hannigan JH, Pilati ML (1991) The effects of chronic postweaning amphetamine on rats exposed to alcohol in utero: weight gain and behavior. Neurotoxicol Teratol 13:649–656 CrossRef
34.
go back to reference Ulug S, Riley EP (1983) The effect of methylphenidate on overactivity in rats prenatally exposed to alcohol. Neurobehav Toxicol Teratol 5:35–39 PubMed Ulug S, Riley EP (1983) The effect of methylphenidate on overactivity in rats prenatally exposed to alcohol. Neurobehav Toxicol Teratol 5:35–39 PubMed
35.
go back to reference Means LCM, Hughes V, Grey K (1984) Rats exposed in utero to ethanol are hyperresponsive to methylphenidate when tested as neonates or adults. Neurobehav Toxicol Teratol 6:187–192 PubMed Means LCM, Hughes V, Grey K (1984) Rats exposed in utero to ethanol are hyperresponsive to methylphenidate when tested as neonates or adults. Neurobehav Toxicol Teratol 6:187–192 PubMed
36.
go back to reference Juarez J, Guerrero-Alvarez A (2015) Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol. Behav Neurosci 129:756–764 CrossRef Juarez J, Guerrero-Alvarez A (2015) Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol. Behav Neurosci 129:756–764 CrossRef
37.
go back to reference Glass L, Graham DM, Deweese BN, Jones KL, Riley EP, Mattson SN (2014) Correspondence of parent report and laboratory measures of inattention and hyperactivity in children with heavy prenatal alcohol exposure. Neurotoxicol Teratol 42:43–50 CrossRef Glass L, Graham DM, Deweese BN, Jones KL, Riley EP, Mattson SN (2014) Correspondence of parent report and laboratory measures of inattention and hyperactivity in children with heavy prenatal alcohol exposure. Neurotoxicol Teratol 42:43–50 CrossRef
38.
go back to reference Hanlon-Dearman A, Chen ML, Olson HC (2018) Understanding and managing sleep disruption in children with Fetal Alcohol Spectrum Disorder. Biochem Cell Biol 96:267–274 CrossRef Hanlon-Dearman A, Chen ML, Olson HC (2018) Understanding and managing sleep disruption in children with Fetal Alcohol Spectrum Disorder. Biochem Cell Biol 96:267–274 CrossRef
39.
go back to reference Durr MR, Petryk S, Mela M, Des Roches A, Wekerle M, Newaz S (2021) Utilization of psychotropic medications in children with FASD: a retrospective review. BMC Pediatr 21:512 Durr MR, Petryk S, Mela M, Des Roches A, Wekerle M, Newaz S (2021) Utilization of psychotropic medications in children with FASD: a retrospective review. BMC Pediatr 21:512
Metagegevens
Titel
Effectiveness of Psychotropic Medications in Children with Prenatal Alcohol and Drug Exposures: A Case Series and Model of Care
Auteurs
Gaby J. Ritfeld
Julie A. Kable
Jennifer E. Holton
Claire D. Coles
Publicatiedatum
01-10-2022
Uitgeverij
Springer US
Gepubliceerd in
Child Psychiatry & Human Development
Print ISSN: 0009-398X
Elektronisch ISSN: 1573-3327
DOI
https://doi.org/10.1007/s10578-022-01451-3